Suppression of Intestinal Polyposis in Mdr1-Deficient Apcmin/ Mice1

Total Page:16

File Type:pdf, Size:1020Kb

Suppression of Intestinal Polyposis in Mdr1-Deficient Apcmin/ Mice1 [CANCER RESEARCH 63, 895–901, March 1, 2003] Advances in Brief Suppression of Intestinal Polyposis in Mdr1-deficient ApcMin/؉ Mice1 Tesshi Yamada,2 Yasuharu Mori, Reiko Hayashi, Mizuho Takada, Yoshinori Ino, Yasuyoshi Naishiro, Tadashi Kondo, and Setsuo Hirohashi Cancer Proteomics Project, National Cancer Center Research Institute, Tokyo 104-0045, Japan Abstract functional involvement of the MDR1 gene in intestinal tumorigenesis. We report suppression of intestinal tumorigenesis in ApcMin/ϩ mice ␤ Aberrant transactivation of a certain set of target genes by the -catenin lacking functional Mdr1 genes. and T-cell factor/lymphoid enhancer factor complex has been considered crucial for the initiation of intestinal tumorigenesis. The human multidrug Materials and Methods resistance (MDR)1 (ABCB1) gene contains multiple ␤-catenin–T-cell factor4- binding elements in its promoter and is one of the immediate targets of the Antibodies, Immunoblot Analyses, Immunohistochemistry, and Immu- complex. In the current study, we have further substantiated the biological nofluorescence Microscopy. Anti-␤-catenin monoclonal antibody (clone 14) involvement of MDR1 in intestinal tumorigenesis based on the following was purchased from BD Transduction Laboratories (San Diego, CA). Anti-␤- evidence: (a) aberrant induction of the Mdr1a (Abcb1a) gene product, P- catenin (C-18), anti-MDR (C-19 and H-241), and anti-actin (C-11) polyclonal glycoprotein, associated with nuclear accumulation of the ␤-catenin protein, antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, was observed even in nascent microscopic adenomas of Min mice; (b) Mdr1- CA). Immunoblot analyses and immunohistochemistry were performed essen- ؉ ؊ ؊ deficient Min (ApcMin/ Mdr1a/b / ) mice developed significantly fewer intes- tially as described previously (8). For immunofluorescence microscopy, cells ؉ ؉ ؉ tinal polyps than did ApcMin/ Mdr1a/b / mice; and (c) Inhibitors of P- were grown on type-I-collagen-coated coverslips (Asahi Technoglass, Tokyo, glycoprotein, verapamil, and cyclosporin A had a suppressive effect on the in Japan), fixed with 10% buffered formalin, and incubated with anti-␤-catenin vitro polypoid growth of IEC6 expressing stabilized (⌬N89) ␤-catenin protein. monoclonal antibody overnight. After incubation with Alexa Fluor 488-labeled Inhibitors of P-glycoprotein may be included in a novel class of chemopre- goat antimouse IgG (Molecular Probes, Eugene, OR), the coverslips were ventive agents against colorectal carcinogenesis. inspected with a laser scanning confocal microscope (Bio-Rad, Hercules, CA). Reverse Transcription-PCR. Total RNA was prepared from adrenal Introduction gland, normal small intestine, and polyp tissues of Min mice (C57BL/6J- ApcMin/ϩ) with TRIzol (Invitrogen, Carlsbad, CA). A 1-␮g sample of DNase- Mutational inactivation of the tumor suppressor gene APC3 is the I-treated total RNA was reverse transcribed and amplified by PCR. The earliest and most frequent genetic event in colorectal carcinogenesis following PCR primers were used: for Mdr1a, 5Ј-TGAAGCTTGTA- ␤ (1). Its inactivation causes IECs to accumulate cytoplasmic -catenin AATCTAAGGAT-3Ј and 5Ј-TGAAAGAAATGATCCCAAGGAT-3Ј; for protein and allows the formation of complexes between ␤-catenin and Mdr1b, 5Ј-TAATGCTTATGGATCCCAGAGT-3Ј and 5Ј-TTTCATGGTCA- TCF/LEF family transcription factors. Aberrant transactivation of a TCATCTCTTGA-3Ј; for Mdr3, 5Ј-ATTTGAAGTTGAGCTAAGTGAC-3Ј certain set of target genes by the ␤-catenin and TCF4/LEF complexes and 5Ј-ATAGCTATCATCTCAGACAGGA-3Ј; for cytokeratin 19, 5Ј-TT- has been considered crucial for the initiation of intestinal carcinogen- GAGATTGAGCTGCAGTCCCAGCT-3Ј and 5Ј-TTCCCAGGGGAGTCTC- esis, and several downstream targets of the complex have already been GCTGGTAGC-3Ј; for GAPDH (glyceraldehyde-3 phosphate dehydrogenase), identified, including c-myc, PPAR-␦, cyclin-D1, TCF-1, c-jun, fra-1, rodent GAPDH forward and reverse primers (Applied Biosystems (Foster City, matrylisin (MMP-7), gastrin, ectodermal-neural cortex 1, laminin ␥2, CA). PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining. ITF-2, and axin2 (Axil) (2–7). We demonstrated previously that the ␤ Mdr1 and Apc Compound Mutant Mice. Animal experiments were per- human MDR1 (ABCB1) gene contains multiple -catenin–TCF4- formed in accordance with the guidelines of the National Cancer Center binding elements in its promoter and is an immediate target of the Research Institute (Tokyo, Japan). C57BL/6J male Min (ApcMin/ϩ) mice (12) complex (8). These target genes are likely to be important mediators were obtained from The Jackson Laboratory (Bar Harbor, ME), and FVB of intestinal carcinogenesis and good candidates for chemoprevention female Mdr1a/b double knockout mice (Mdr1aϪ/Ϫ/Mdr1bϪ/Ϫ; Ref. 13) were of colorectal cancer by molecular targeting. However, because with a obtained from Taconic Farms (Germantown, NY). The genotyping of the few exceptions (3, 9–11) the functional connection of these down- animals is described in Fig. 2 and its legends. N6F1 pups were housed under stream target genes with intestinal carcinogenesis has remained un- identical conditions and sacrificed at 15 weeks of age. The gut was filled with explored, in this study, we adopted a genetic approach to clarify the 10% buffered formalin via the anus immediately after sacrifice and then opened longitudinally. After overnight fixation, specimens were stained briefly with 0.5% methylene blue. The numbers and major diameters of polyps in the Received 10/24/02; accepted 1/20/03. small and large intestine were measured in the ϫ20 power field of a dissecting The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with microscope (Nikon, Tokyo, Japan). Formalin-fixed, paraffin-embedded sec- 18 U.S.C. Section 1734 solely to indicate this fact. tions were stained by standard H&E techniques. 1 Supported by grants from the Ministry of Health, Labor, and Welfare; the Ministry Cell Lines and Tetracycline-inducible Retroviral Expression. An im- of Education, Culture, Sports, Science and Technology, Japan; and the Program for mortalized rat small cell line, IEC6 (14), was obtained from the Riken Cell Promotion of Fundamental Studies in Health Sciences of the Organization for Pharma- ceutical Safety and Research of Japan. Y. M. and Y. N. are recipients of a Research Bank (Tsukuba, Japan) and cultivated in DMEM containing 5% Tet-system- Resident Fellowship from the Foundation for Promotion of Cancer Research. approved fetal bovine serum (BD Biosciences Clontech, Palo Alto, CA) and 4 2 To whom requests for reprints should be addressed, at Cancer Proteomics Project, ␮g/ml insulin (Invitrogen). A colorectal cancer cell line, DLD1, was obtained National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, from the Health Science Research Resources Bank (Osaka, Japan; Ref. 8). Japan. Phone: 81-3-3542-2511, extension 4054; Fax: 81-3-3547-5298; E-mail: [email protected]. We used the RevTet-Off gene expression system (BD Biosciences Clon- 3 Abbreviations used are: APC, adenomatous polyposis coli; MDR, multidrug resist- tech) to introduce the tetracycline-regulatory element, tTA, and subsequently ance; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IEC, intestinal epithelial cell; the Rev-TRE carrying AU1-tagged human ␤Ϫcatenin cDNA lacking the FAP, familial adenomatous polyposis; TCF, T-cell factor; LEF, lymphoid enhancer factor; NH2-terminal 89 amino acids (15), into IEC6 cells. Details of preparation of ABC, ATP-binding cassette; NSAID nonsteroidal anti-inflammatory drug; Min, multiple ␤ ⌬ intestinal neoplasia; Mom1, modifier of multiple intestinal neoplasia-1; Mom, modifier of the pRev-TRE -catenin N89 plasmid construct are available on request. multiple intestinal neoplasia; PAF, platelet-activating factor; Dox, doxycycline. Cells were infected for 24 h in the presence of 8 ␮g/ml Polybrene (Sigma, St. 895 Downloaded from cancerres.aacrjournals.org on October 1, 2021. © 2003 American Association for Cancer Research. Ϫ Ϫ ϩ SUPPRESSION OF POLYPOSIS IN MDR1 / APCMIN/ MICE Fig. 1. Increased expression of P-glycoprotein in intestinal adenoma of Min mice. Immunoperoxi- dase staining was performed on serial sections ex- posed to anti-␤-catenin (C-18; A, B, and E) and anti-P-glycoprotein (C-19; C, D, and F) polyclonal antibodies. A and B, expression of ␤-catenin pro- tein in an adenomatous polyp of a Min mouse (C57BL/6J-ApcMin/ϩ). Original magnification: ϫ40 (A) and ϫ200 (B). C and D, expression of P-glycoprotein in the same polyp as in A and B. Original magnification: ϫ40 (C) and ϫ200 (D). E and F, ␤-catenin (E) and P-glycoprotein (F) expres- sion in a univillous adenoma. Original magnifica- tion: ϫ100. G, mRNA expression of Mdr1a, Mdr1b, Mdr3, cytokeratin 19 (Cy19), and GAPDH in adrenal gland (Ad.), normal small intestinal (N), and adenomatous (T) tissue of Min mice. Cyto- keratin 19 was included to monitor the endodermal contribution (6). GAPDH was included to monitor the integrity of the cDNA templates. Louis, MO) with conditioned medium containing ecotropic retroviral particles, Dual Luciferase Reporter Assay. We used a pair of luciferase reporter as described previously (16) and cloned by limiting dilution with uninfected constructs, TOP-FLASH and FOP-FLASH (Upstate, Placid, NY), to evaluate cells as feeder layers. TCF/LEF transcriptional activity (16). Cells
Recommended publications
  • Keratin 19 Regulates Cell Shape and Cell-Cell Adhesion of MCF7 Cells While Maintaining E-Cadherin Localization at the Cell Surface
    Keratin 19 regulates cell shape and cell-cell adhesion of MCF7 cells while maintaining E-cadherin localization at the cell surface Welcome to my poster. This is Sarah Alsharif, a PhD student from the biology department. I am glad to present the work our lab has been doing in the breast cancer field. In fact, after lung cancer, breast cancer is the second cause of death in women worldwide (1). It is estimated that every 18 seconds, approximately one new case of breast cancer is documented (2). No one dies due to cancer itself. The death is because of metastasis which takes place when cancer cells leave a breast in which they are formed and reach other sites such as the brain or lung. Our lab is interested in investigating the mechanism behind metastasis of breast cancer. Metastasis is associated with what is called epithelial to mesenchymal transition (EMT), the process characterized by loss of cell to cell adhesion and expression of epithelial markers such as keratin intermediate filament proteins, as you can see in the first three images of cells. Those filaments are keratins and they are critical for the shape and for maintaining mechanical integrity of epithelial cells via cell to cell complexes called desmosomes. Among different keratins, keratin 19 (K19) is highly expressed in many types of cancer including breast cancer, and is correlated with a worse prognosis (3). Consistently, K19 expression has been reported to be significantly higher in metastatic breast cancer tumor cells compared to primary tumors (4). The role of K19 on mechanical properties of cancer cells for cell migration and possible impact on metastasis in breast cancer patients is still unknown.
    [Show full text]
  • Quantigene Flowrna Probe Sets Currently Available
    QuantiGene FlowRNA Probe Sets Currently Available Accession No. Species Symbol Gene Name Catalog No. NM_003452 Human ZNF189 zinc finger protein 189 VA1-10009 NM_000057 Human BLM Bloom syndrome VA1-10010 NM_005269 Human GLI glioma-associated oncogene homolog (zinc finger protein) VA1-10011 NM_002614 Human PDZK1 PDZ domain containing 1 VA1-10015 NM_003225 Human TFF1 Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) VA1-10016 NM_002276 Human KRT19 keratin 19 VA1-10022 NM_002659 Human PLAUR plasminogen activator, urokinase receptor VA1-10025 NM_017669 Human ERCC6L excision repair cross-complementing rodent repair deficiency, complementation group 6-like VA1-10029 NM_017699 Human SIDT1 SID1 transmembrane family, member 1 VA1-10032 NM_000077 Human CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) VA1-10040 NM_003150 Human STAT3 signal transducer and activator of transcripton 3 (acute-phase response factor) VA1-10046 NM_004707 Human ATG12 ATG12 autophagy related 12 homolog (S. cerevisiae) VA1-10047 NM_000737 Human CGB chorionic gonadotropin, beta polypeptide VA1-10048 NM_001017420 Human ESCO2 establishment of cohesion 1 homolog 2 (S. cerevisiae) VA1-10050 NM_197978 Human HEMGN hemogen VA1-10051 NM_001738 Human CA1 Carbonic anhydrase I VA1-10052 NM_000184 Human HBG2 Hemoglobin, gamma G VA1-10053 NM_005330 Human HBE1 Hemoglobin, epsilon 1 VA1-10054 NR_003367 Human PVT1 Pvt1 oncogene homolog (mouse) VA1-10061 NM_000454 Human SOD1 Superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))
    [Show full text]
  • Knock-Out Validated Antibodies from Cloud-Clone Cat.No
    Knock-out validated antibodies from Cloud-Clone Cat.No. Target PAA778Hu01 B-Cell Leukemia/Lymphoma 2 (Bcl2) PAL763Hu01 Myxovirus Resistance 1 (MX1) PAB698Hu01 Lactate Dehydrogenase B (LDHB) PAA009Hu01 Angiopoietin 2 (ANGPT2) PAA849Ra01 Glycogen Phosphorylase, Liver (PYGL) PAA153Hu01 Alpha-Fetoprotein (aFP) PAF460Hu01 Folate Receptor 1, Adult (FOLR1) PAB233Hu01 Cyclin Dependent Kinase 4 (CDK4) PAA150Hu04 Carcinoembryonic Antigen (CEA) PAB905Hu01 Interleukin 7 Receptor (IL7R) PAC823Hu01 Thymidine Kinase 1, Soluble (TK1) PAH838Hu01 Isocitrate Dehydrogenase 2, mitochondrial (IDH2) PAK078Mu01 Fas Associating Death Domain Containing Protein (FADD) PAA537Hu01 Enolase, Neuron Specific (NSE) PAA651Hu01 Hyaluronan Binding Protein 1 (HABP1) PAB215Hu02 Fibrinogen Beta (FGb) PAB769Hu01 S100 Calcium Binding Protein A6 (S100A6) PAB231Hu01 Keratin 18 (KRT18) PAH839Hu01 Isocitrate Dehydrogenase 1, Soluble (IDH1) PAE748Hu01 Karyopherin Alpha 2 (KPNa2) PAB081Hu02 Heat Shock 70kDa Protein 1A (HSPA1A) PAA778Mu01 B-Cell Leukemia/Lymphoma 2 (Bcl2) PAA853Hu03 Caspase 8 (CASP8) PAA399Mu01 High Mobility Group Protein 1 (HMG1) PAA303Mu01 Galectin 3 (GAL3) PAA537Mu02 Enolase, Neuron Specific (NSE) PAA994Ra01 Acid Phosphatase 1 (ACP1) PAB083Ra01 Superoxide Dismutase 2, Mitochondrial (SOD2) PAB449Mu01 Enolase, Non Neuronal (NNE) PAA376Mu01 Actinin Alpha 2 (ACTN2) PAA553Ra01 Matrix Metalloproteinase 9 (MMP9) PAA929Bo01 Retinol Binding Protein 4, Plasma (RBP4) PAA491Ra02 Keratin 2 (KRT2) PAC025Hu01 Keratin 8 (KRT8) PAB231Mu01 Keratin 18 (KRT18) PAC598Hu03 Vanin 1 (VNN1)
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • Overexpression of Kru¨Ppel-Like Factor 4 in the Human Colon Cancer Cell Line RKO Leads to Reduced Tumorigenecity
    Oncogene (2003) 22, 3424–3430 & 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc Overexpression of Kru¨ ppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity Duyen T Dang*,1, Xinming Chen2, Jing Feng1, Michael Torbenson3, Long H Dang4 and Vincent W Yang2,5 1Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; 2Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA; 3Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; 4The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; 5Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA Kru¨ ppel-like factor 4 (KLF4) is a zinc-finger-containing KLF4 is expressed during cortical differentiation sug- transcription factor, the expression of which is enriched in gesting a role in T-lymphocyte differentiation (Panigada the postmitotic cells of the intestinal epithelium. KLF4 is a et al., 1999). KLF4 is also highly expressed in the testes, target gene of the tumor suppressor adenomatous poly- specifically in the postmeiotic germ cells and somatic posis coli (APC). We sought to determine the role of Sertoli cells, suggesting an important role in testicular KLF4 in suppressing the tumorigenecity of RKO colon differentiation (Behr and Kaestner, 2002). Finally, cancer cells, which do not express KLF4. We utilized an KLF4 is expressed in vascular endothelial cells (Yet established system in RKO cells, in which an inducible et al., 1998), and may function to inhibit TGF-b- promoter controls expression of KLF4.
    [Show full text]
  • Toward Unraveling the Complexity of Simple Epithelial Keratins in Human Disease
    Toward unraveling the complexity of simple epithelial keratins in human disease M. Bishr Omary, … , Pavel Strnad, Shinichiro Hanada J Clin Invest. 2009;119(7):1794-1805. https://doi.org/10.1172/JCI37762. Review Series Simple epithelial keratins (SEKs) are found primarily in single-layered simple epithelia and include keratin 7 (K7), K8, K18–K20, and K23. Genetically engineered mice that lack SEKs or overexpress mutant SEKs have helped illuminate several keratin functions and served as important disease models. Insight into the contribution of SEKs to human disease has indicated that K8 and K18 are the major constituents of Mallory-Denk bodies, hepatic inclusions associated with several liver diseases, and are essential for inclusion formation. Furthermore, mutations in the genes encoding K8, K18, and K19 predispose individuals to a variety of liver diseases. Hence, as we discuss here, the SEK cytoskeleton is involved in the orchestration of several important cellular functions and contributes to the pathogenesis of human liver disease. Find the latest version: https://jci.me/37762/pdf Review series Toward unraveling the complexity of simple epithelial keratins in human disease M. Bishr Omary,1 Nam-On Ku,1,2 Pavel Strnad,3 and Shinichiro Hanada1,4 1Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA. 2Department of Biomedical Sciences, Graduate School, Yonsei University, Seoul, Republic of Korea. 3Department of Internal Medicine I, University Medical Center Ulm, Ulm, Germany. 4Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. Simple epithelial keratins (SEKs) are found primarily in single-layered simple epithelia and include keratin 7 (K7), K8, K18–K20, and K23.
    [Show full text]
  • Effector Gene Expression Potential to Th17 Cells by Promoting Microrna
    Downloaded from http://www.jimmunol.org/ by guest on September 26, 2021 is online at: average * The Journal of Immunology published online 17 May 2013 from submission to initial decision 4 weeks from acceptance to publication http://www.jimmunol.org/content/early/2013/05/17/jimmun ol.1300351 MicroRNA-155 Confers Encephalogenic Potential to Th17 Cells by Promoting Effector Gene Expression Ruozhen Hu, Thomas B. Huffaker, Dominique A. Kagele, Marah C. Runtsch, Erin Bake, Aadel A. Chaudhuri, June L. Round and Ryan M. O'Connell J Immunol Submit online. Every submission reviewed by practicing scientists ? is published twice each month by http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://www.jimmunol.org/content/suppl/2013/05/17/jimmunol.130035 1.DC1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 26, 2021. Published May 17, 2013, doi:10.4049/jimmunol.1300351 The Journal of Immunology MicroRNA-155 Confers Encephalogenic Potential to Th17 Cells by Promoting Effector Gene Expression Ruozhen Hu,* Thomas B. Huffaker,* Dominique A. Kagele,* Marah C. Runtsch,* Erin Bake,* Aadel A. Chaudhuri,† June L.
    [Show full text]
  • Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Ria Rosser
    Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Ria Rosser January 2016 Supervisors: BM Corfe and KS Chapple Department of Oncology Thesis submitted to the University of Sheffield for the degree of Doctor of Medicine 2 Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Table of Contents Abstract ................................................................................................................................. 7 Acknowledgments ............................................................................................................. 9 List of Figures ................................................................................................................... 11 List of Tables .................................................................................................................... 13 Abbreviations .................................................................................................................. 15 Chapter 1 Literature review ....................................................................................... 19 1.1 The History of Adenomatous polyps ................................................................. 19 1.1.1 Origins of the Adenoma ............................................................................................... 20 1.1.2 Adenoma-Carcinogenesis model ......................................................................................... 24 1.2 Field effects – Theory and Definitions .............................................................
    [Show full text]
  • View Board (IRB) at Tuskegee University
    Myers et al. BMC Cancer (2017) 17:480 DOI 10.1186/s12885-017-3462-7 RESEARCH ARTICLE Open Access Proteomic characterization of paired non- malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins Jennifer S. Myers1, Karin A. Vallega1, Jason White2, Kaixian Yu3, Clayton C. Yates2 and Qing-Xiang Amy Sang1* Abstract Background: While many factors may contribute to the higher prostate cancer incidence and mortality experienced by African-American men compared to their counterparts, the contribution of tumor biology is underexplored due to inadequate availability of African-American patient-derived cell lines and specimens. Here, we characterize the proteomes of non-malignant RC-77 N/E and malignant RC-77 T/E prostate epithelial cell lines previously established from prostate specimens from the same African-American patient with early stage primary prostate cancer. Methods: In this comparative proteomic analysis of RC-77 N/E and RC-77 T/E cells, differentially expressed proteins were identified and analyzed for overrepresentation of PANTHER protein classes, Gene Ontology annotations, and pathways. The enrichment of gene sets and pathway significance were assessed using Gene Set Enrichment Analysis and Signaling Pathway Impact Analysis, respectively. The gene and protein expression data of age- and stage-matched prostate cancer specimens from The Cancer Genome Atlas were analyzed. Results: Structural and cytoskeletal proteins were differentially expressed and statistically overrepresented between RC-77 N/E and RC-77 T/E cells. Beta-catenin, alpha-actinin-1, and filamin-A were upregulated in the tumorigenic RC-77 T/E cells, while integrin beta-1, integrin alpha-6, caveolin-1, laminin subunit gamma-2, and CD44 antigen were downregulated.
    [Show full text]
  • Terrestrial Vertebrates Have Two Keratin Gene Clusters; Striking Differences in Teleost fish Alexander Zimek, Klaus Weberã
    ARTICLE IN PRESS European Journal of Cell Biology 84 (2005) 623–635 www.elsevier.de/ejcb Terrestrial vertebrates have two keratin gene clusters; striking differences in teleost fish Alexander Zimek, Klaus Weberà Department of Biochemistry and Cell Biology, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, D-37077 Go¨ttingen, Germany Received 16 December 2004; received in revised form 25 January 2005; accepted 25 January 2005 Abstract Keratins I and II form the largest subgroups of mammalian intermediate filament (IF) proteins and account as obligatory heteropolymers for the keratin filaments of epithelia. All human type I genes except for the K18 gene are clustered on chromosome 17q21, while all type II genes form a cluster on chromosome 12q13, that ends with the type I gene K18. Highly related keratin gene clusters are found in rat and mouse. Since fish seem to lack a keratin II cluster we screened the recently established draft genomes of a bird (chicken) and an amphibian (Xenopus). The results show that keratin I and II gene clusters are a feature of all terrestrial vertebrates. Because hair with its multiple hair keratins and inner root sheath keratins is a mammalian acquisition, the keratin gene clusters of chicken and Xenopus tropicalis have only about half the number of genes found in mammals. Within the type I clusters all genes have the same orientation. In type II clusters there is a rare gene of opposite orientation. Finally we show that the genes for keratins 8 and 18, which are the first expression pair in embryology, are not only adjacent in mammals, but also in Xenopus and three different fish.
    [Show full text]
  • Rho Gtpase Signalling Pathways in the Morphological Changes Associated with Apoptosis
    Cell Death and Differentiation (2002) 9, 493 ± 504 ã 2002 Nature Publishing Group All rights reserved 1350-9047/02 $25.00 www.nature.com/cdd Review Rho GTPase signalling pathways in the morphological changes associated with apoptosis ML Coleman1 and MF Olson*,1 membrane blebs and apoptotic bodies (reviewed in refer- ence3). Ultimately, the dead cell is packaged into membrane- 1 Cancer Research Campaign Centre for Cell and Molecular Biology, Institute of clad apoptotic bodies that facilitate uptake by neighbouring Cancer Research, 237 Fulham Road, London SW3 6JB, UK cells or by specialised phagocytic cells. Dynamic re- * Corresponding author: MF Olson, Abramson Family Cancer Research arrangements of the actin cytoskeleton in the phagocyte are Institute, Room 411, BRB II/III, 421 Curie Boulevard, University of required for the internalisation of apoptotic cell fragments. Pennsylvania, Philadelphia, PA 19104-6160, USA. Tel: +1 215 746 6798; Fax: +1 215 746 5525; E-mail: [email protected] Recent research has revealed the importance of signal transduction pathways controlled by Rho family GTPases in Received 23.8.01; revised 26.10.01; accepted 5.11.01 regulating the marked changes in cell morphology observed Edited by M Piacentini in the processes of apoptosis and phagocytosis. The Rho GTPases are a family of proteins (RhoA, RhoB, RhoC, RhoD, RhoE/Rnd3, RhoG, RhoH/TTF, Rnd1, Rnd2, Abstract Rac1, Rac2, Rac3, Cdc42/G25K, Wrch-1, TC10, TCL, Chp, Rif) that act as molecular switches in intracellular signal The killing and removal of superfluous cells is an important 4 step during embryonic development, tissue homeostasis, transduction pathways (reviewed in reference ).
    [Show full text]